RNS Number : 8992C
Pantheon International PLC
25 February 2022
 

For immediate release

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, Canada, Australia (other than to persons who are both wholesale clients and professional or sophisticated investors in Australia), Japan, the Republic of South Africa or any other jurisdiction where its release, publication or distribution is or may be unlawful.

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 

1.

Details of person discharging managerial responsibilities/person closely associated with them

a)

Name

David Melvin and Alexandra Melvin

2.

Reason for the notification

a)

Position / status

David Melvin - Director/PDMR

Alexandra Melvin - Spouse & Person Closely Associated with David Melvin

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pantheon International Plc

b)

LEI

2138001B3CE5S5PEE928

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary shares of 6.7 pence each

 


GB00BP37WF17

b)

Nature of the transaction

Purchase of Ordinary shares held jointly by David Melvin and Alexandra Melvin

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£3.0150

163

£3.02

4,837

d)

Aggregated information

- Aggregated volume

 

- Price

 


 5,000

 

15,099.19

e)

Date of the transaction

25 February 2022

f)

Place of the transaction

London Stock Exchange

25 February 2022

Enquiries:

Pantheon

Helen Steers / Vicki Bradley

020 3356 1800

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEFFDIEESEEE